That most protein molecules do not last as long as the cell in which they reside was suggested more than 60 years ago, by studies that utilized stable isotopes to label proteins in vivo (Schoenheimer, 1942) . Despite this evidence, the prevailing view, until the 1980s, was that intracellular protein degradation was a simple and even mundane process, serving largely to dispose of "aged" or otherwise damaged proteins. Cellular regulation was believed to be a separate affair, mediated primarily by repressors and activators of gene expression, which were assumed, often tacitly, to be long-lived. Among the reasons for this lopsided perspective was the difficulty of connecting the long-recognized proteolytic system in the lysosomes to specific pathways of intracellular regulation. Thus, most people studying gene expression in the 1960s and 1970s assumed that the regulatory circuits they cared about did not involve short-lived proteins. As we know now, just the opposite proved true, especially in eukaryotes, where many transcriptional regulators are conditionally short-lived proteins whose levels in a cell are determined by the rates of their ubiquitin-dependent proteolysis at least as much as by the rates of their synthesis. Although the constricting premodern view of the functions of intracellular proteolysis wasn't shared by everyone (see, for example, Schimke and Doyle, 1971; Poole et al., 1978) , definitive evidence for the importance of extralysosomal protein degradation had to wait until the ts85 studies Ciechanover et al., 1984) .
Ubiquitin, a 76 residue protein, was identified by G. Goldstein and colleagues (Goldstein et al., 1975) , who detected this protein, of unknown function, in many different organisms, and gave it a name that in hindsight is remarkably apt. The first covalent ubiquitin conjugate, to histone H2A, was described in 1977 (Goldknopf and Busch, 1977) . In 1978, A. Hershko and his graduate students A. Ciechanover and Y. Hod reported that a small heat-stable protein was required for the degradation of denatured globin added to rabbit reticulocyte extracts (Ciechanover et al., 1978) . In 1980, Hershko, Ciechanover and colleagues, in a collaboration with I. Rose, demonstrated that the above heat-stable protein, *Correspondence: avarsh@caltech.edu termed APF-1 (ATP-dependent proteolytic factor 1), was conjugated to proteins in an ATP-dependent reaction, and proposed that this event marked conjugated proteins for selective degradation Ciechanover et al., 1980) . Also during this period, it was realized, through the work by K. Wilkinson, M. Urban, and A. Haas (Wilkinson et al., 1980) , that APF-1 and ubiquitin were in fact the same protein.
In 1980-1983, Hershko, Ciechanover, and their colleagues in the Hershko laboratory dissected the enzymatic cascade of ubiquitin conjugation. The initial step was shown to involve ubiquitin-activating enzyme, termed El, which catalyzed an ATP-dependent reaction in which the C-terminal Gly residue of ubiquitin was covalently linked, via a thioester bond, to a specific Cys residue of El. The activated, El-linked ubiquitin moiety was transesterified to specific Cys residues of the ubiquitin-conjugating enzymes (E2s), which thereafter mediated the conjugation of ubiquitin to ~-amino groups of Lys residues in substrates of the ubiquitin system (Hershko et al., 1983) . That E2 existed as a family of related but distinct enzymes was demonstrated by Pickart and Rose (1985) . Yet another set of proteins, termed E3s, was also required for the conjugation reaction, apparently playing a role in substrate recognition (Hershko et al., 1983) . Another study (Hershko et al., 1984) showed that proteins conjugated to ubiquitin were targeted for degradation by a large ATP-dependent protease that became known later, through the work of several laboratories, as the 26S proteasome (Hough et al., 1986 ; reviewed by Zwickl et al., 2000) . For a historical account of the early biochemical work, see Hershko et al. (2000) . These essential studies defined the enzymology of ubiquitin conjugation, but did not address the nature of its specificity and particularly its physiological functions. Consequently, there was, at the time, widespread skepticism concerning the physiological significance of this strange new protein modification. At the beginning of 1982, Ciechanover, having completed his graduate studies with Hershko, arrived to MIT for his postdoctoral work in the laboratory of H. Lodish.
A. Varshavsky, another protagonist of ts85 studies, emigrated from Russia to the U.S. in 1977. He joined the faculty of MIT's Biology Department, and resumed work on the structure of chromosomes, the subject of his earlier research in Moscow. In 1978, Varshavsky came across the above-mentioned 1977 paper by the Busch laboratory (Goldknopf and Busch, 1977 ) that described the ubiquitin-H2A conjugate (Ub-H2A), and decided to determine the distribution of this conjugate amongst the chromatin's nucleosomes. Back in Russia, he had begun to develop a method for high-resolution analysis of nucleosomes. These DNA-protein complexes were subjected to electrophoresis in a low-ionic-strength polyacrylamide gel (a forerunner of the gel shift assay), followed by second-dimension electrophoresis of either DNA or proteins. Varshavsky and his postdoctoral student L. Levinger located Ub-H2A in a subset of the nucleosomes, succeeded in separating these nucleosomes from those lacking Ub-H2A, and showed that nucleosomes containing Ub-H2A were enriched in transcribed genes and excluded from the centromeric heterochromatin Varshavsky, 1980, 1982) .
In 1980, Varshavsky saw the paper by Wilkinson et al. (1980) about the identity of ubiquitin and APF-1. Two seemingly independent realms, protein degradation and chromosomes, came together for him, suggesting a regulatory pathway of immense complexity and broad, still to be discovered, range of functions. Varshavsky decided to find genetic approaches to the entire problem, because a system of such complexity was unlikely to be understood through biochemistry alone. In 1980, reverse genetic techniques were about to become feasible with the yeast Saccharomyces cerevisiae, but were still a decade away from mammalian genetics. Near the end of 1980, Varshavsky came across a paper by M. Yamada and colleagues that described a conditionally lethal, temperature-sensitive mouse cell line called ts85. The researchers showed that a specific nuclear protein disappeared from ts85 cells at increased temperatures, and suggested that this protein might be Ub-H2A (Marunouchi et al., 1980) . From the paper's data, Varshavsky concluded that the protein in question was virtually certain to be Ub-H2A, because in the preceding two years his laboratory had learned much about the properties of this ubiquitin conjugate. On the hunch that mouse ts85 cells might be mutated in a component of the ubiquitin system, Varshavsky wrote to Yamada, and received from him, in 1981, both ts85 and the parental ("wild-type") cell line called FM3A.
D. Finley, the third protagonist of ts85 studies, and the one who spearheaded this project, joined the Varshavsky laboratory as a graduate student, and soon began a systematic study of ts85. A few months into the project, Finley and Varshavsky made the crucial observation that ubiquitin conjugation in an extract from ts85 cells was temperature-sensitive, in contrast to an extract from parental cells (Figure 3 in Finley et al., 1984) . Soon afterward, Varshavsky invited Ciechanover, who had been working on unrelated projects in the Lodish laboratory, to join him and Finley in the ongoing study of ts85 cells. Ciechanover did, the work continued, and they eventually submitted two papers Ciechanover et al., 1984) that described, primarily, the following discoveries:
• mouse ts85 cells have a temperature-sensitive ubiquitin-activating (El) enzyme.
• these cells, in contrast to their wild-type counterpart, stop degrading the bulk of their short-lived proteins at nonpermissive temperature.
This was the first evidence that ubiquitin conjugation was required for protein degradation in vivo. The results with ts85 cells also indicated that ubiquitin conjugation was essential for cell viability . In addition, ts85 cells were preferentially arrested at the G2 phase of the cell cycle, and the synthesis of heatstress proteins was strongly induced in these cells at nonpermissive temperature, indicating that ubiquitin conjugation was involved in the cell cycle progression and stress response (Finley et al., , 1988 . In 1983, T. Hunt and colleagues discovered unusual proteins in clam embryos (Evans et al., 1983) . These proteins, which they called cyclins, were degraded during exit from mitosis. We suggested that cyclins were destroyed by the ubiquitin system , a hypothesis shown to be correct in 1991, by M. Glotzer, A. Murray, and M. Kirschner (Glotzer et al., 1991) , and independently by Hershko and colleagues (Hershko et al., 1991) . In one of our two papers, a specific (and at the time entirely original) hypothesis was suggested about the mechanism of action of heat-stress proteins. It was proposed that the ubiquitin-dependent proteolytic pathway and the heat shock response are complementary systems designed (among other things) to prevent cellular damage that abnormal proteins could inflict .... It is possible that at least some of the heat shock proteins recognize the same binding sites by which abnormal proteins recognize each other in precipitate formation, but bind monovalently to abnormal proteins so as to prevent precipitate formation .
At the time of this hypothesis, which proved correct, published speculations on the mechanism of heatstress proteins centered primarily on RNA and chromatin regulation (Marx, 1983) ; the era of modern understanding commenced soon after the ts85 work (see, for example, Munro and Pelham, 1985) . Our other 1984 proposal was that specific heat-stress proteins such as HSP70 and the ubiquitin-dependent proteolysis play complementary roles in containing and reversing stress damage through the recognition of unfolded proteins via exposed hydrophobic surfaces . This has also proven correct, as illustrated by numerous papers, and with particular clarity by the recent finding that overexpression of ubiquitin can rescue stress resistance of cells with an impaired expression of heat-stress proteins (Friant et al., 2003) . Analogous demonstrations of the functional coupling between chaperones and proteolysis have been made in prokaryotic systems (Burton et al., 2001 , and references therein).
In addition to having been a breakthrough that indicated the importance, indeed the requirement, of the ubiquitin system for intracellular proteolysis, cell viability, and cell cycle progression, the two ts85 papers were also the first instance of a study that addressed the in vivo workings of this system. The ts85 papers were thus a watershed in more ways than one. They underlay the subsequent expansion of the ubiquitin field as well as the later scientific strategy by the Varshavsky laboratory. Although the ts85 discoveries left little doubt, among the optimists, about the importance of the ubiquitin system in cellular physiology, it was difficult to extend these findings in the same system, owing to limitations of the mammalian somatic cell genetics, which was still hampered at that time by the impossibility of altering genes at will. In addition, the advances with ts85 cells did not address the existence and nature of degradation signals, that is, features of proteins that make them targets for ubiquitin conjugation.
Therefore, in 1983, even before the completion of ts85 work, Finley and Varshavsky, together with other colleagues in the Varshavsky lab, began systematic analysis of the ubiquitin system in the genetically tractable S. cerevisiae, a project that soon expanded to occupy the entire laboratory. Between 1983 and 1990, this work, a direct descendant of the ts85 approach, established the physiological fundamentals of the ubiquitin field. Mentioned below are the key advances of those early years. In 1984, Finley, E. Ozkaynak, and Varshavsky cloned the first ubiquitin gene, and found it to encode a polyubiquitin precursor protein (Ozkaynak et al., 1984) . By 1987, they showed that this gene, UBI4, was strongly induced by different stresses, and that a deletion of UBI4 resulted in stress-hypersensitive cells (Finley et al., 1987) , These results validated some of the above described ideas that grew out of the ts85 experiments , thereby establishing one broad and essential function of the ubiquitin system. In 1986, A. Bachmair, Finley, and Varshavsky discovered, through the development of the ubiquitin fusion technique, the first degradation signals (degrons) that target proteins for ubiquitin conjugation and proteolysis (Bachmair et al., 1986) . One set of these degradation signals gives rise to the N-end rule, which relates the in vivo halflife of a protein to the identity of its N-terminal residue (Bachmair et al., 1986) . The discovery and dissection of this pathway (Bachmair et al., 1986; Ferber and Ciechanover, 1987; Reiss et al., 1988; Bachmair and Varshavsky, 1989) revealed that most of the test substrates in the earlier studies (Hershko et al., 1983) were, in fact, N-end rule substrates.
In 1987, S. Jentsch, J. McGrath, and Varshavsky discovered that RAD6, a protein known to yeast geneticists as an essential component of DNA repair pathways, was a ubiquitin-conjugating (E2) enzyme, the first such enzyme to mediate a specific physiological function (Jentsch et al., 1987) . A subsequent collaboration between B. Byers' and Varshavsky's laboratories demonstrated that CDC34, an essential cell cycle regulator, was also a ubiquitin-conjugating enzyme (Goebl et al., 1988) . This result extended the ubiquitin-cell cycle connection of our ts85 work to the first demonstration of a specific function of ubiquitin conjugation in cell cycle control.
Soon thereafter, Finley, B. Bartel, and Varshavsky discovered the functions of the other yeast ubiquitin genes, UBI1-UBI3, which were shown to encode fusions of ubiquitin to one protein of the large ribosomal subunit and one protein of the small ribosomal subunit (Finley et al., 1989) . The presence of ubiquitin in front of a ribosomal protein moiety was found to be extremely transient, yet essential for the efficient biogenesis of ribosomes. Ubiquitin acts, in these settings, not as a degradation signal but as a cotranslational chaperone (Finley et al., 1989) . (Redman and Rechsteiner [1989] independently identified the orthologous ubiquitin fusions in mammals.) The first nonproteolytic function of ubiquitin, mediated by its fusions to ribosomal proteins (Finley et al., 1989) , appeared to be an exceptional case until years later, when L. Hicke and H. Riezman discovered that ubiquitylation of a plasma membrane-embedded receptor signals its endocytosis (Hicke and Riezman, 1996) . Ubiquitin is now recognized to have numerous nonproteolytic functions.
In 1989, V. Chau and colleagues in the Varshavsky laboratory demonstrated the existence and unique topology of polyubiquitin chains (Chau et al., 1989) , suggested in an earlier study by Hershko and Heller (1985) . Chau et al. (1989) also showed that a substrate-linked polyubiquitin chain was essential for the substrate's degradation by the proteasome, another beginning of what, nowadays, is a major area of ubiquitin studies. In 1990, E, Johnson, D. Gonda, and Varshavsky discovered that ubiquitin-dependent proteolysis of oligomeric proteins is subunit-selective, a fundamental feature of the ubiquitin system that allows protein degradation to be wielded as an instrument of either negative or positive control (Johnson et al., 1990) . Among many examples are activation of the transcription factor NF-KB, through selective degradation of the inhibitory subunit IKB, and inactivation of the cyclin-dependent kinases, through selective degradation of their cyclin subunits.
By the early 1990s, several physiological substrates of the ubiquitin system were identified, including MAT~2 (Hochstrasser and Varshavsky, 1990; Hochstrasser et al., 1991) , p53, Myc, Fos (Scheffner et al., 1990; Ciechanover et al., 1991) , and cyclins (Glotzer et al., 1991; Hershko et al., 1991) . More and more laboratories began to study the ubiquitin system. The trickle became a flood, and today research on ubiquitin is going from strength to strength in hundreds of laboratories throughout the world. Within a decade from now, we will probably see useful drugs that target specific components of the ubiquitin system, and also, with luck, drugs that will direct this system to destroy (and thereby to functionally inactivate) any specific protein. Ubiquitin studies are now one of the largest and most important arenas of modern biology, the point of convergence of many disparate disciplines. The ts85 work Ciechanover et al., 1984) played a key role in bringing about this major change in outlook, in that it established the ubiquitin system as the dominant pathway for selective protein degradation and at the same time revealed the broad significance of this process.
